This study aimed to determine the plasma concentrations of five biomarkers of AD pathology (amyloidβ −40, amyloidβ–42, p-tau217, GFAP and NfL) among 967 community-dwelling older Nigerian Africans and explore their association with cognitive phenotypes. This evidence concerns the gene GFAP and Alzheimer disease.